内視鏡的粘膜下層剥離術(ESD)市場 : 2027年までの世界予測

出版:MarketsandMarkets(マーケッツアンドマーケッツ) 出版年月:2023年 1月

内視鏡的粘膜下層剥離術(ESD)市場 : 製品 (保持、クリップ、胃カメラ、結腸鏡)、適応症 (がん (食道、胃、結腸)、エンドユーザー (病院、外来手術センター、専門クリニック) – 2027年までの世界予測
Endoscopic Submucosal Dissection Market by Product (Grasp, Clips, Gastroscopes, Colonoscopes), Indication (Cancer (Esophageal, Stomach, Colon), End User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics) – Global Forecast to 2027

ページ数 197
図表数 177
種別 英文調査報告書
価格

レポート目次    お問合せ・ご注文    価格・納期について

無料サンプル

The global endoscopic submucosal dissection market is projected to reach USD 483 million by 2027 from USD 347 million in 2022, at a CAGR of 6.9%.

Endoscopic Submucosal Dissection Market by Product (Grasp, Clips, Gastroscopes, Colonoscopes), Indication (Cancer (Esophageal, Stomach, Colon), End User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics) - Global Forecast to 2027

Endoscopic submucosal dissection (ESD) is an advanced therapeutic endoscopy technique for superficial gastrointestinal neoplasms. In endoscopic submucosal dissection, the equipment includes different types of knives, forceps, snares, and a few other products that support the procedure, as well as accessories used to ease the handling of instruments during surgeries.

The global endoscopic submucosal dissection market is projected to reach USD 483 million by 2027 from USD 347 million in 2022, at a CAGR of 6.9%. Growth in this market is largely driven by the increasing use of endoscopy in detection and treatment procedures, the rising prevalence of cancer, and the growing geriatric population. On the other hand, the dearth of skilled professionals is a key factor restraining the growth of this market.

The gastroscopes and colonoscopes segment accounted for the largest share of the global endoscopic submucosal dissection market
In 2021, the gastroscopes and colonoscopes segment holds the largest share of the global endoscopic submucosal dissection market. The large share of this segment can be attributed to the higher adoption rate of this equipment by end users, the rising preference of patients and doctors for minimally invasive procedures, and ongoing technological advancements in endoscopy procedures.

The stomach cancer segment accounted for the largest share of the endoscopic submucosal dissection market in 2021

Based on indication, the endoscopic submucosal dissection market is segmented into esophageal cancer stomach cancer, colon cancer. The stomach cancer segment holds the largest share of the endoscopic submucosal dissection market in 2021. The large share of this segment can be attributed to the increasing geriatric population in the US, China, Japan, and India and the rising incidence of stomach cancer.

The hospitals’ segment is expected to dominate the endoscopic submucosal dissection market during the forecast period
Based on end user, the endoscopic submucosal dissection market is segmented into ambulatory surgical centers, hospitals, specialty clinics, and other end users. The hospitals segment holds the largest share of the endoscopic submucosal dissection market during the forecast period owing to the the increasing per capita income and growing healthcare awareness.

North America dominated the endoscopic submucosal dissection market in 2021

North America dominated the endoscopic submucosal dissection market in 2021. The large share of North America in the global market is attributed to the favorable reimbursement policies for endoscopic procedures in the US, the increasing prevalence of cancer, high investments by hospitals to purchase new equipment and adopt new endoscopic procedures, strong focus on research activities to improve endoscopy techniques, as well as the implementation of a new funding model by Canadian hospitals.

The study contains insights from various industry experts, ranging from component suppliers to Tier 1 companies and OEMs. The break-up of the primaries is as follows:
• By Company Type– Tier 1- 34%, Tier 2- 38% Tier 3 – 28%
• By Designation— C level – 26%, Managers & Other Level – 74%
• By Region— North America – 17%, Europe – 39%, Asia Pacific – 28%
Key players in the endoscopic submucosal dissection market

The prominent players in the endoscopic submucosal dissection market are Olympus Corporation (Japan), Boston Scientific Corporation (US), Sumitomo Bakelite Co., Ltd. (Japan), Creo Medical Group PLC (UK), Medtronic (Ireland), HOYA Corporation (Japan), ConMed Corporation (US), Steris Plc (Ireland), FUJIFILM Holdings Corporation (Japan), MTW Endoskopie Manufaktur (Germany), Ovesco Endoscopy AG (Germany), Zeon Medical Inc. (Japan), Micro-Tech Endoscopy (China), Karl Storz SE & CO. KG (Germany), Cook Medical (US), Leo Medical Co., Ltd. (China), Erbe Elektromedizin GmbH (Germany), Taewoong Medical Co., Ltd. (South Korea), DCC Healthcare Limited (Ireland), Kossen Co., Ltd. (South Korea), INNOVAMEDICA S.p.A. (Italy), Jiangsu Vedkang Medical Science and Technology Co., Ltd. (China), Hangzhou AGS Medical Technological Co., Ltd. (China), and Beijing ZKSK Technology Co., Ltd. (China).

内視鏡的粘膜下層剥離術(ESD)市場 : 製品 (保持、クリップ、胃カメラ、結腸鏡)、適応症 (がん (食道、胃、結腸)、エンドユーザー (病院、外来手術センター、専門クリニック) - 2027年までの世界予測 Endoscopic Submucosal Dissection Market by Product (Grasp, Clips, Gastroscopes, Colonoscopes), Indication (Cancer (Esophageal, Stomach, Colon), End User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics) - Global Forecast to 2027
Research Coverage:
The report analyzes the endoscopic submucosal dissection market and aims at estimating the market size and future growth potential of this market based on various segments such asproduct, indication, end user and region. The report also includes a product portfolio matrix of various endoscopic submucosal dissection products available in the market. The report also provides a competitive analysis of the key players in this market, along with their company profiles, product offerings, and key market strategies.
Reasons to Buy the Report
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them, garner a more significant share of the market. Firms purchasing the report could use one or any combination of the below-mentioned strategies to strengthen their position in the market.
This report provides insights into the following pointers:
• Market Penetration: Comprehensive information on product portfolios offered by the top players in the global endoscopic submucosal dissection market. The report analyzes this market by product, indication, end user and region.
• Product Enhancement/Innovation: Detailed insights on upcoming trends and product launches in the global endoscopic submucosal dissection market.
• Market Development: Comprehensive information on the lucrative emerging markets byproduct, indication, end user and region.
• Market Diversification: Exhaustive information about new products or product enhancements, growing geographies, recent developments, and investments in the global endoscopic submucosal dissection market.
• Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, competitive leadership mapping, and capabilities of leading players in the global endoscopic submucosal dissection market.


目次

1 INTRODUCTION 26
1.1 STUDY OBJECTIVES 26
1.2 MARKET DEFINITION 27
1.2.1 INCLUSIONS AND EXCLUSIONS 27
1.3 MARKET SCOPE 28
1.3.1 MARKETS COVERED 28
FIGURE 1 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SEGMENTATION 28
1.4 YEARS CONSIDERED 29
1.5 CURRENCY CONSIDERED 29
TABLE 1 STANDARD CURRENCY CONVERSION RATES 29
1.6 SCOPE-RELATED LIMITATIONS 30
1.7 STAKEHOLDERS 30
2 RESEARCH METHODOLOGY 31
2.1 RESEARCH DATA 31
FIGURE 2 RESEARCH DESIGN 31
2.1.1 SECONDARY DATA 31
2.1.1.1 Key data from secondary sources 33
2.1.2 PRIMARY DATA 33
FIGURE 3 PRIMARY SOURCES 33
2.1.2.1 Key data from primary sources 34
2.1.2.2 Key industry insights 35
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 35
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION 36
FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION 36
2.2 MARKET SIZE ESTIMATION 37
FIGURE 7 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 37
FIGURE 8 REVENUE SHARE ANALYSIS ILLUSTRATION: OLYMPUS CORPORATION 38
FIGURE 9 SUPPLY-SIDE MARKET SIZE ESTIMATION: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET (2021) 39
FIGURE 10 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2022–2027) 40
FIGURE 11 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 41
FIGURE 12 TOP-DOWN APPROACH 41
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 42
FIGURE 13 DATA TRIANGULATION METHODOLOGY 43
2.4 MARKET SHARE ESTIMATION 43
2.5 STUDY ASSUMPTIONS 44
2.6 METHODOLOGY-RELATED LIMITATIONS 44
2.7 RISK ASSESSMENT 44
TABLE 2 RISK ASSESSMENT: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET 44
3 EXECUTIVE SUMMARY 45
FIGURE 14 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2022 VS. 2027 (USD MILLION) 45
FIGURE 15 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2022 VS. 2027 (USD MILLION) 46
FIGURE 16 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2022 VS. 2027 (USD MILLION) 46
FIGURE 17 GEOGRAPHIC SNAPSHOT OF ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET 47
4 PREMIUM INSIGHTS 48
4.1 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET OVERVIEW 48
FIGURE 18 INCREASING USE OF ENDOSCOPY IN DETECTION AND TREATMENT PROCEDURES TO DRIVE MARKET GROWTH 48
4.2 ASIA PACIFIC: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT AND COUNTRY 49
FIGURE 19 GASTROSCOPES AND COLONOSCOPES HELD LARGEST SHARE OF ASIA PACIFIC MARKET IN 2021 49
4.3 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: GEOGRAPHIC MIX 50
FIGURE 20 MARKET IN ASIA PACIFIC TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD 50
4.4 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: REGIONAL MIX 51
FIGURE 21 NORTH AMERICA TO BE LARGEST MARKET FOR ENDOSCOPIC SUBMUCOSAL DISSECTION PRODUCTS THROUGHOUT FORECAST PERIOD 51
4.5 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: DEVELOPED VS. DEVELOPING MARKETS 51
FIGURE 22 DEVELOPING MARKETS TO REGISTER HIGHER GROWTH RATE DURING FORECAST PERIOD 51
5 MARKET OVERVIEW 52
5.1 INTRODUCTION 52
5.2 MARKET DYNAMICS 52
FIGURE 23 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 52
5.2.1 DRIVERS 53
5.2.1.1 Increasing use of endoscopy in detection and treatment procedures 53
5.2.1.2 Rising prevalence of cancer 53
FIGURE 24 GLOBAL CANCER INCIDENCE, 2008–2030 54
5.2.1.3 Growing geriatric population 54
FIGURE 25 SHARE OF GERIATRIC POPULATION, BY REGION (2010–2030) 55
TABLE 3 GLOBAL CANCER INCIDENCE FOR GERIATRIC POPULATION (65–85+), 2020 VS. 2040 55
5.2.2 RESTRAINTS 55
5.2.2.1 Dearth of skilled professionals 55
5.2.2.2 High overhead cost of ESD procedures with limited reimbursements 56
5.2.3 OPPORTUNITIES 56
5.2.3.1 Growing demand for minimally invasive procedures 56
5.2.3.2 Growing investments in research and development of endoscopy technology 56
TABLE 4 MAJOR DEVELOPMENTS 57
5.2.3.3 Expected increase in adoption of and preference for endoscopic submucosal dissection procedures in developing countries 57
5.2.4 CHALLENGES 58
5.2.4.1 Higher rate of complications 58
5.2.4.2 Risk of post-operative infection 58
5.3 INDUSTRY TRENDS 59
5.3.1 ADVANCES IN TRACTION METHODS FOR ENDOSCOPIC SUBMUCOSAL DISSECTION 59
5.3.2 ROBOT-ASSISTED ENDOSCOPIC SUBMUCOSAL DISSECTION 60
5.4 REGULATORY ANALYSIS 61
5.4.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 61
TABLE 5 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 61
TABLE 6 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 62
TABLE 7 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 62
5.4.2 NORTH AMERICA 63
5.4.2.1 US 63
5.4.2.2 Canada 63
5.4.3 EUROPE 63
5.4.3.1 Germany 64
5.4.3.2 France 64
5.4.3.3 UK 64
5.4.3.4 Italy 65
5.5 ECOSYSTEM MARKET MAP 65
FIGURE 26 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: ECOSYSTEM MARKET MAP 66
5.6 VALUE CHAIN ANALYSIS 66
FIGURE 27 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: VALUE CHAIN ANALYSIS 67
5.7 PORTER’S FIVE FORCES ANALYSIS 67
TABLE 8 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: PORTER’S FIVE FORCES ANALYSIS 67
5.7.1 THREAT OF NEW ENTRANTS 68
5.7.1.1 High capital requirement 68
5.7.1.2 High preference for products from well-established brands 68
5.7.2 THREAT OF SUBSTITUTES 68
5.7.2.1 Presence of substitute therapies for endoscopic submucosal dissection 68
5.7.3 BARGAINING POWER OF SUPPLIERS 68
5.7.3.1 Presence of several raw material suppliers 69
5.7.3.2 Supplier switching cost 69
5.7.4 BARGAINING POWER OF BUYERS 69
5.7.4.1 Limited number of companies offering premium products at global level 69
5.7.5 INTENSITY OF COMPETITIVE RIVALRY 69
5.7.5.1 Increasing demand for high-quality and innovative products 69
5.7.5.2 Lucrative growth potential in emerging markets 69
5.8 INDICATIVE PRICING MODEL ANALYSIS 69
TABLE 9 AVERAGE SELLING PRICE, BY PRODUCT (USD) 70
5.9 PATENT ANALYSIS 70
5.9.1 PATENT PUBLICATION TRENDS FOR ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET 70
FIGURE 28 GLOBAL PATENT PUBLICATION TRENDS IN ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, 2015–2022 71
5.9.2 TOP APPLICANTS (COMPANIES) FOR PATENTS RELATED TO ENDOSCOPIC SUBMUCOSAL DISSECTION DEVICES AND MATERIALS 71
FIGURE 29 TOP COMPANIES THAT APPLIED FOR PATENTS RELATED TO ENDOSCOPIC SUBMUCOSAL DISSECTION DEVICES AND MATERIALS, 2015–2022 71
5.9.3 JURISDICTION ANALYSIS: TOP APPLICANTS (COUNTRIES) FOR PATENTS IN ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET 72
FIGURE 30 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR PATENTS IN ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, 2015–2022 72
5.10 SUPPLY CHAIN ANALYSIS 72
FIGURE 31 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: STAKEHOLDERS IN SUPPLY CHAIN 73
5.11 KEY CONFERENCES AND EVENTS DURING 2022–2023 74
TABLE 10 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: DETAILED LIST OF CONFERENCES AND EVENTS 74
5.12 KEY STAKEHOLDERS AND BUYING CRITERIA 75
5.12.1 KEY STAKEHOLDERS IN BUYING PROCESS 75
FIGURE 32 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP 3 APPLICATIONS 75
TABLE 11 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP 3 APPLICATIONS 75
5.12.2 BUYING CRITERIA 75
FIGURE 33 KEY BUYING CRITERIA FOR TOP 3 APPLICATIONS 75
TABLE 12 KEY BUYING CRITERIA FOR TOP 3 APPLICATIONS 76
6 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT 77
6.1 INTRODUCTION 78
TABLE 13 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 78
6.2 GASTROSCOPES AND COLONOSCOPES 78
6.2.1 RISE IN COLON CANCER INCIDENCE TO DRIVE GROWTH 78
TABLE 14 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET FOR GASTROSCOPES AND COLONOSCOPES, BY COUNTRY, 2020–2027 (USD MILLION) 79
6.3 KNIVES 80
6.3.1 IMPROVED EFFICACY, SAFETY, AND COST-EFFECTIVENESS OF KNIVES TO DRIVE MARKET GROWTH 80
TABLE 15 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET FOR KNIVES, BY COUNTRY, 2020–2027 (USD MILLION) 80
6.4 INJECTION AGENTS 81
6.4.1 NEED FOR LOW-COST INJECTION AGENTS TO BOOST GROWTH 81
TABLE 16 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET FOR INJECTION AGENTS, BY COUNTRY, 2020–2027 (USD MILLION) 81
6.5 TISSUE RETRACTORS 82
6.5.1 RISING NUMBER OF SURGICAL PROCEDURES TO AID ADOPTION OF TISSUE RETRACTORS 82
TABLE 17 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET FOR TISSUE RETRACTORS, BY COUNTRY, 2020–2027 (USD MILLION) 82
6.6 GRASPERS/CLIPS 83
6.6.1 PATIENT SAFETY AND HIGH PRECISION OFFERED BY GRASPERS TO DRIVE THEIR DEMAND 83
TABLE 18 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET FOR GRASPERS/CLIPS, BY COUNTRY, 2020–2027 (USD MILLION) 83
6.7 OTHER PRODUCTS 84
TABLE 19 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET FOR OTHER PRODUCTS, BY COUNTRY, 2020–2027 (USD MILLION) 84
7 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION 85
7.1 INTRODUCTION 86
TABLE 20 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2020–2027 (USD MILLION) 86
TABLE 21 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2021 (NUMBER OF PROCEDURES) 86
7.2 STOMACH CANCER 87
7.2.1 STOMACH CANCER OR GASTRIC CANCER ASSOCIATED WITH SIGNIFICANT PROPORTION OF ALL CANCER DEATHS 87
TABLE 22 ESTIMATED NUMBER OF NEW CASES OF STOMACH CANCER, BY REGION (2020–2040) 87
TABLE 23 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET FOR STOMACH CANCER, BY COUNTRY, 2020–2027 (USD MILLION) 88
TABLE 24 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET FOR STOMACH CANCER, BY REGION, 2021 (NUMBER OF PROCEDURES) 88
7.3 COLON CANCER 89
7.3.1 COLON CANCER IS THIRD-MOST-COMMON CANCER AND SECOND-LEADING CAUSE OF CANCER DEATHS WORLDWIDE 89
TABLE 25 ESTIMATED NUMBER OF NEW CASES OF COLON CANCER, BY REGION (2020–2040) 89
TABLE 26 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET FOR COLON CANCER, BY COUNTRY, 2020–2027 (USD MILLION) 90
TABLE 27 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET FOR COLON CANCER, BY REGION, 2021 (NUMBER OF PROCEDURES) 90
7.4 ESOPHAGEAL CANCER 91
7.4.1 GROWING PREVALENCE OF ESOPHAGEAL CANCER ATTRIBUTED TO EXCESS TOBACCO AND ALCOHOL USE 91
TABLE 28 ESTIMATED NUMBER OF NEW CASES OF ESOPHAGEAL CANCER, BY REGION (2020–2040) 91
TABLE 29 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET FOR ESOPHAGEAL CANCER, BY COUNTRY, 2020–2027 (USD MILLION) 92
TABLE 30 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET FOR ESOPHAGEAL CANCER, BY REGION, 2021 (NUMBER OF PROCEDURES) 92
8 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER 93
8.1 INTRODUCTION 94
TABLE 31 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2020–2027 (USD MILLION) 94
8.2 HOSPITALS 94
8.2.1 GROWING PREFERENCE FOR MINIMALLY INVASIVE SURGERIES AND ESD PROCEDURES TO SUPPORT GROWTH 94
TABLE 32 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET FOR HOSPITALS, BY COUNTRY, 2020–2027 (USD MILLION) 95
8.3 SPECIALTY CLINICS 95
8.3.1 TRANSITION FROM HOSPITAL-BASED PROCEDURES TO CLINIC-BASED PROCEDURES TO BOOST GROWTH 95
TABLE 33 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET FOR SPECIALTY CLINICS, BY COUNTRY, 2020–2027 (USD MILLION) 96
8.4 AMBULATORY SURGICAL CENTERS 97
8.4.1 GROWTH IN ASC SEGMENT DRIVEN BY INCREASING NUMBER OF OUTPATIENT VISITS 97
TABLE 34 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET FOR AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2020–2027 (USD MILLION) 98
8.5 OTHER END USERS 98
TABLE 35 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET FOR OTHER END USERS, BY COUNTRY, 2020–2027 (USD MILLION) 99
9 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY REGION 100
9.1 INTRODUCTION 101
FIGURE 34 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 101
TABLE 36 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY REGION, 2020–2027 (USD MILLION) 102
9.2 NORTH AMERICA 102
FIGURE 35 NORTH AMERICA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SNAPSHOT 103
TABLE 37 NORTH AMERICA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 103
TABLE 38 NORTH AMERICA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 104
TABLE 39 NORTH AMERICA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2020–2027 (USD MILLION) 104
TABLE 40 NORTH AMERICA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2020–2027 (USD MILLION) 104
9.2.1 US 105
9.2.1.1 US is largest market for endoscopic submucosal dissection products 105
TABLE 41 US: MACROECONOMIC INDICATORS 106
TABLE 42 US: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 106
TABLE 43 US: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2020–2027 (USD MILLION) 106
TABLE 44 US: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2020–2027 (USD MILLION) 107
9.2.2 CANADA 107
9.2.2.1 Slower healthcare development in Canada over past decade to restrain growth 107
TABLE 45 AGE-STANDARDIZED INCIDENCE RATES (ASIR) FOR SELECTED CANCERS IN MEN AND WOMEN IN CANADA, 2020 VS. 2040 108
TABLE 46 CANADA: MACROECONOMIC INDICATORS 109
TABLE 47 CANADA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 109
TABLE 48 CANADA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2020–2027 (USD MILLION) 109
TABLE 49 CANADA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2020–2027 (USD MILLION) 110
9.3 EUROPE 110
TABLE 50 EUROPE: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 110
TABLE 51 EUROPE: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 111
TABLE 52 EUROPE: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2020–2027 (USD MILLION) 111
TABLE 53 EUROPE: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2020–2027 (USD MILLION) 111
9.3.1 GERMANY 112
9.3.1.1 Germany to account for largest share of European market 112
TABLE 54 GERMANY: MACROECONOMIC INDICATORS 112
TABLE 55 GERMANY: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 113
TABLE 56 GERMANY: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2020–2027 (USD MILLION) 113
TABLE 57 GERMANY: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2020–2027 (USD MILLION) 113
9.3.2 FRANCE 114
9.3.2.1 High-quality healthcare system offering coverage to all citizens to support market growth 114
TABLE 58 FRANCE: MACROECONOMIC INDICATORS 114
TABLE 59 FRANCE: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 115
TABLE 60 FRANCE: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2020–2027 (USD MILLION) 115
TABLE 61 FRANCE: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2020–2027 (USD MILLION) 115
9.3.3 UK 116
9.3.3.1 Investments by hospitals to purchase new and advanced endoscopic submucosal dissection equipment to propel market 116
TABLE 62 UK: MACROECONOMIC INDICATORS 116
TABLE 63 UK: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 117
TABLE 64 UK: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2020–2027 (USD MILLION) 117
TABLE 65 UK: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2020–2027 (USD MILLION) 117
9.3.4 ITALY 118
9.3.4.1 Receptivity of government toward high-quality and technologically advanced equipment to foster growth 118
TABLE 66 ITALY: MACROECONOMIC INDICATORS 118
TABLE 67 ITALY: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 119
TABLE 68 ITALY: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2020–2027 (USD MILLION) 119
TABLE 69 ITALY: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2020–2027 (USD MILLION) 119
9.3.5 SPAIN 120
9.3.5.1 Rising prevalence of cancer to drive market growth 120
TABLE 70 SPAIN: MACROECONOMIC INDICATORS 120
TABLE 71 SPAIN: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 120
TABLE 72 SPAIN: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2020–2027 (USD MILLION) 121
TABLE 73 SPAIN: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2020–2027 (USD MILLION) 121
9.3.6 REST OF EUROPE 121
TABLE 74 ROE: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 122
TABLE 75 ROE: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2020–2027 (USD MILLION) 122
TABLE 76 ROE: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2020–2027 (USD MILLION) 123
9.4 ASIA PACIFIC 123
FIGURE 36 ASIA PACIFIC: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SNAPSHOT 124
TABLE 77 ASIA PACIFIC: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 125
TABLE 78 ASIA PACIFIC: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 125
TABLE 79 ASIA PACIFIC: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2020–2027 (USD MILLION) 125
TABLE 80 ASIA PACIFIC: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2020–2027 (USD MILLION) 126
9.4.1 JAPAN 126
9.4.1.1 Supportive medical device reimbursement policies to drive market growth 126
TABLE 81 JAPAN: MACROECONOMIC INDICATORS 127
TABLE 82 JAPAN: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 127
TABLE 83 JAPAN: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2020–2027 (USD MILLION) 127
TABLE 84 JAPAN: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2020–2027 (USD MILLION) 128
9.4.2 CHINA 128
9.4.2.1 Large patient population and strong need for healthcare infrastructure improvements to boost market growth 128
TABLE 85 CHINA: MACROECONOMIC INDICATORS 129
TABLE 86 CHINA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 129
TABLE 87 CHINA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2020–2027 (USD MILLION) 129
TABLE 88 CHINA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2020–2027 (USD MILLION) 130
9.4.3 INDIA 130
9.4.3.1 Favorable government initiatives for healthcare infrastructure improvements to support market growth 130
TABLE 89 INDIA: MACROECONOMIC INDICATORS 131
TABLE 90 INDIA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 131
TABLE 91 INDIA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2020–2027 (USD MILLION) 131
TABLE 92 INDIA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2020–2027 (USD MILLION) 132
9.4.4 REST OF ASIA PACIFIC 132
TABLE 93 ROAPAC: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 133
TABLE 94 ROAPAC: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2020–2027 (USD MILLION) 133
TABLE 95 ROAPAC: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2020–2027 (USD MILLION) 133
9.5 LATIN AMERICA 134
9.5.1 INCREASING PURCHASING POWER AND HEALTHCARE AFFORDABILITY WILL FAVOR MARKET GROWTH 134
TABLE 96 LATIN AMERICA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 135
TABLE 97 LATIN AMERICA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2020–2027 (USD MILLION) 135
TABLE 98 LATIN AMERICA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2020–2027 (USD MILLION) 135
9.6 MIDDLE EAST AND AFRICA 136
9.6.1 HEALTHCARE INFRASTRUCTURAL ADVANCEMENTS WILL CREATE NEED FOR HOSPITAL EQUIPMENT AND MEDICAL DEVICES 136
TABLE 99 MIDDLE EAST & AFRICA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 136
TABLE 100 MIDDLE EAST & AFRICA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2020–2027 (USD MILLION) 137
TABLE 101 MIDDLE EAST & AFRICA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2020–2027 (USD MILLION) 137
10 COMPETITIVE LANDSCAPE 138
10.1 INTRODUCTION 138
10.2 STRATEGIES ADOPTED BY KEY PLAYERS 138
10.3 REVENUE ANALYSIS OF KEY MARKET PLAYERS 139
FIGURE 37 REVENUE ANALYSIS OF KEY PLAYERS OPERATING IN ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET 139
10.4 MARKET SHARE ANALYSIS 139
FIGURE 38 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SHARE, BY KEY PLAYER (2021) 140
10.5 COMPANY FOOTPRINT ANALYSIS 140
10.5.1 FOOTPRINT OF COMPANIES, BY PRODUCT 141
10.5.2 FOOTPRINT OF COMPANIES, BY END USER 142
10.5.3 FOOTPRINT OF COMPANIES, BY REGION 143
10.6 COMPANY EVALUATION MATRIX 144
10.6.1 STARS 144
10.6.2 EMERGING LEADERS 144
10.6.3 PERVASIVE PLAYERS 144
10.6.4 PARTICIPANTS 144
FIGURE 39 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: COMPANY EVALUATION MATRIX 145
10.7 COMPETITIVE BENCHMARKING 146
TABLE 102 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: KEY START-UPS/SMES 146
10.8 COMPETITIVE SCENARIO 146
10.8.1 PRODUCT LAUNCHES 147
TABLE 103 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: PRODUCT LAUNCHES (JANUARY 2019–DECEMBER 2022) 147
10.8.2 DEALS 148
TABLE 104 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: DEALS (JANUARY 2019–DECEMBER 2022) 148
10.8.3 OTHER DEVELOPMENTS 149
TABLE 105 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: OTHER DEVELOPMENTS (JANUARY 2019–DECEMBER 2022) 149
11 COMPANY PROFILES 150
(Business Overview, Products/Solutions/Services Offered, Recent Developments, MnM view (Key strengths/Right to win, Strategic choices made, Weakness/competitive threats)*
11.1 KEY PLAYERS 150
11.1.1 OLYMPUS CORPORATION 150
TABLE 106 OLYMPUS CORPORATION: BUSINESS OVERVIEW 150
FIGURE 40 COMPANY SNAPSHOT: OLYMPUS CORPORATION (2022) 151
11.1.2 FUJIFILM HOLDINGS CORPORATION 154
TABLE 107 FUJIFILM HOLDINGS CORPORATION: BUSINESS OVERVIEW 154
FIGURE 41 COMPANY SNAPSHOT: FUJIFILM HOLDINGS CORPORATION (2021) 155
11.1.3 BOSTON SCIENTIFIC CORPORATION 158
TABLE 108 BOSTON SCIENTIFIC CORPORATION: BUSINESS OVERVIEW 158
FIGURE 42 COMPANY SNAPSHOT: BOSTON SCIENTIFIC CORPORATION (2021) 159
11.1.4 MEDTRONIC 161
TABLE 109 MEDTRONIC: BUSINESS OVERVIEW 161
FIGURE 43 COMPANY SNAPSHOT: MEDTRONIC (2022) 162
11.1.5 SUMITOMO BAKELITE CO., LTD. 164
TABLE 110 SUMITOMO BAKELITE CO., LTD.: BUSINESS OVERVIEW 164
FIGURE 44 COMPANY SNAPSHOT: SUMITOMO BAKELITE CO., LTD. (2021) 165
11.1.6 CREO MEDICAL GROUP PLC 167
TABLE 111 CREO MEDICAL GROUP PLC: BUSINESS OVERVIEW 167
FIGURE 45 COMPANY SNAPSHOT: CREO MEDICAL GROUP PLC (2021) 167
11.1.7 HOYA CORPORATION 170
TABLE 112 HOYA CORPORATION: BUSINESS OVERVIEW 170
FIGURE 46 COMPANY SNAPSHOT: HOYA CORPORATION (2022) 171
11.1.8 CONMED CORPORATION 172
TABLE 113 CONMED CORPORATION: BUSINESS OVERVIEW 172
FIGURE 47 COMPANY SNAPSHOT: CONMED CORPORATION (2021) 173
11.1.9 STERIS PLC 174
TABLE 114 STERIS PLC: BUSINESS OVERVIEW 174
FIGURE 48 COMPANY SNAPSHOT: STERIS PLC (2022) 175
11.1.10 MTW ENDOSKOPIE MANUFAKTUR 177
TABLE 115 MTW ENDOSKOPIE MANUFAKTUR: BUSINESS OVERVIEW 177
11.2 OTHER PLAYERS 178
11.2.1 OVESCO ENDOSCOPY AG 178
TABLE 116 OVESCO ENDOSCOPY AG: BUSINESS OVERVIEW 178
11.2.2 ZEON MEDICAL INC. 179
TABLE 117 ZEON MEDICAL INC.: BUSINESS OVERVIEW 179
11.2.3 MICRO-TECH ENDOSCOPY 180
TABLE 118 MICRO-TECH ENDOSCOPY: BUSINESS OVERVIEW 180
11.2.4 KARL STORZ SE & CO. KG 182
TABLE 119 KARL STORZ SE & CO. KG.: BUSINESS OVERVIEW 182
11.2.5 COOK MEDICAL 183
TABLE 120 COOK MEDICAL: BUSINESS OVERVIEW 183
11.2.6 LEO MEDICAL CO., LTD. 185
TABLE 121 LEO MEDICAL CO., LTD.: BUSINESS OVERVIEW 185
11.2.7 ERBE ELEKTROMEDIZIN GMBH 186
TABLE 122 ERBE ELEKTROMEDIZIN GMBH: BUSINESS OVERVIEW 186
11.2.8 TAEWOONG MEDICAL CO., LTD. 187
TABLE 123 TAEWOONG MEDICAL CO., LTD.: BUSINESS OVERVIEW 187
11.2.9 DCC HEALTHCARE LIMITED 188
TABLE 124 DCC HEALTHCARE LIMITED: BUSINESS OVERVIEW 188
11.2.10 KOSSEN CO., LTD. 189
TABLE 125 KOSSEN CO., LTD.: BUSINESS OVERVIEW 189
11.2.11 INNOVAMEDICA S.P.A. 190
TABLE 126 INNOVAMEDICA S.P.A.: BUSINESS OVERVIEW 190
11.2.12 JIANGSU VEDKANG MEDICAL SCIENCE AND TECHNOLOGY CO., LTD. 191
TABLE 127 JIANGSU VEDKANG MEDICAL SCIENCE AND TECHNOLOGY CO., LTD.: BUSINESS OVERVIEW 191
11.2.13 HANGZHOU AGS MEDICAL TECHNOLOGICAL CO., LTD. 192
TABLE 128 HANGZHOU AGS MEDICAL TECHNOLOGICAL CO., LTD.: BUSINESS OVERVIEW 192
11.2.14 BEIJING ZKSK TECHNOLOGY CO., LTD. 193
TABLE 129 BEIJING ZKSK TECHNOLOGY CO., LTD.: BUSINESS OVERVIEW 193
*Details on Business Overview, Products/Solutions/Services Offered, Recent Developments, MnM view (Key strengths/Right to win, Strategic choices made, Weakness/competitive threats)* might not be captured in case of unlisted companies.
12 APPENDIX 194
12.1 DISCUSSION GUIDE 194
12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 199
12.3 CUSTOMIZATION OPTIONS 201
12.4 RELATED REPORTS 201
12.5 AUTHOR DETAILS 202


    お問合せフォーム

    • レポートのタイトルは自動で入ります。

    • *のある項目は必須項目です。

    お名前*

    会社名*

    部署名

    メールアドレス*

    電話番号

    当ウェブサイトを知った経緯を教えてください。

    お問合せ内容

    株式会社SEMABIZ・ChosaReport.com プライバシーポリシー

    Eメールでのお問合せもお受けしております。
    下記アドレスへ“(at)”を“@”に変えてお送りください。通常1営業日以内にご返信いたします。
    crinquiry(at)chosareport.com